KCL Infra Projects Ltd
Incorporated in 1995, KCL Infra Projects Ltd is in the business of construction & infrastructure activities, along with providing advisory services.[1]
- Market Cap ₹ 23.5 Cr.
- Current Price ₹ 1.39
- High / Low ₹ 1.80 / 1.20
- Stock P/E 39.1
- Book Value ₹ 3.29
- Dividend Yield 0.00 %
- ROCE 2.22 %
- ROE 0.95 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Stock is trading at 0.42 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -2.86% over past five years.
- Promoter holding is low: 22.9%
- Company has a low return on equity of 1.65% over last 3 years.
- Earnings include an other income of Rs.3.22 Cr.
- Company has high debtors of 169 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.85 | 5.21 | 7.32 | 17.88 | 20.39 | 8.42 | 14.07 | 4.41 | 15.57 | 19.54 | 8.56 | 12.17 | 12.11 | |
| 4.39 | 5.69 | 8.18 | 18.98 | 20.30 | 8.29 | 13.78 | 4.63 | 14.88 | 19.95 | 9.90 | 13.96 | 13.88 | |
| Operating Profit | -0.54 | -0.48 | -0.86 | -1.10 | 0.09 | 0.13 | 0.29 | -0.22 | 0.69 | -0.41 | -1.34 | -1.79 | -1.77 |
| OPM % | -14.03% | -9.21% | -11.75% | -6.15% | 0.44% | 1.54% | 2.06% | -4.99% | 4.43% | -2.10% | -15.65% | -14.71% | -14.62% |
| 1.26 | 1.15 | 1.45 | 1.85 | 0.83 | 0.82 | 0.91 | 0.70 | 0.74 | 2.03 | 3.23 | 3.16 | 3.22 | |
| Interest | 0.25 | 0.26 | 0.25 | 0.37 | 0.45 | 0.48 | 0.44 | 0.26 | 0.70 | 0.48 | 0.62 | 0.57 | 0.55 |
| Depreciation | 0.07 | 0.13 | 0.12 | 0.12 | 0.12 | 0.09 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.05 |
| Profit before tax | 0.40 | 0.28 | 0.22 | 0.26 | 0.35 | 0.38 | 0.68 | 0.14 | 0.65 | 1.06 | 1.19 | 0.73 | 0.85 |
| Tax % | 30.00% | 32.14% | 9.09% | 38.46% | 28.57% | 21.05% | 26.47% | 35.71% | 26.15% | 25.47% | 27.73% | 30.14% | |
| 0.29 | 0.18 | 0.20 | 0.16 | 0.25 | 0.29 | 0.50 | 0.10 | 0.48 | 0.79 | 0.87 | 0.52 | 0.60 | |
| EPS in Rs | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.00 | 0.02 | 0.10 | 0.05 | 0.03 | 0.03 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | -3% |
| 3 Years: | -8% |
| TTM: | 99% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 1% |
| 3 Years: | 3% |
| TTM: | 161% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 19% |
| 3 Years: | -19% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.27 | 5.27 | 5.27 | 5.27 | 5.27 | 5.27 | 5.27 | 5.27 | 5.27 | 24.80 | 38.50 | 33.78 | 33.78 |
| Reserves | 12.74 | 12.92 | 13.12 | 12.86 | 13.11 | 13.40 | 13.90 | 14.00 | 14.48 | 15.26 | 16.14 | 21.38 | 21.72 |
| 1.70 | 2.33 | 1.71 | 3.80 | 3.83 | 3.67 | 3.75 | 3.90 | 3.69 | 4.36 | 3.72 | 3.72 | 3.54 | |
| 3.10 | 0.30 | 3.70 | 1.21 | 5.04 | 2.44 | 10.44 | 12.16 | 19.61 | 8.90 | 5.34 | 12.09 | 15.59 | |
| Total Liabilities | 22.81 | 20.82 | 23.80 | 23.14 | 27.25 | 24.78 | 33.36 | 35.33 | 43.05 | 53.32 | 63.70 | 70.97 | 74.63 |
| 0.43 | 0.72 | 0.63 | 0.53 | 0.42 | 0.28 | 0.67 | 0.59 | 0.52 | 0.44 | 0.37 | 0.35 | 0.33 | |
| CWIP | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.76 | 0.76 | 0.50 | 0.10 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 5.00 |
| 21.62 | 19.24 | 22.67 | 22.51 | 26.82 | 24.50 | 32.69 | 34.74 | 42.53 | 52.88 | 63.33 | 67.62 | 69.30 | |
| Total Assets | 22.81 | 20.82 | 23.80 | 23.14 | 27.25 | 24.78 | 33.36 | 35.33 | 43.05 | 53.32 | 63.70 | 70.97 | 74.63 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.25 | 13.13 | -0.36 | -6.01 | 1.74 | -1.33 | 0.71 | -3.42 | 8.51 | -12.00 | -1.16 | 9.85 | |
| 1.00 | -12.91 | 1.70 | 3.05 | -1.90 | 1.98 | -0.31 | 2.27 | -6.96 | -6.83 | -19.38 | -12.25 | |
| -0.12 | -0.05 | -0.87 | 3.09 | -0.40 | -0.81 | -0.46 | 1.20 | -0.70 | 19.28 | 22.73 | -0.92 | |
| Net Cash Flow | -0.37 | 0.17 | 0.47 | 0.12 | -0.56 | -0.16 | -0.06 | 0.06 | 0.86 | 0.45 | 2.19 | -3.32 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 169.04 | 73.08 | 100.96 | 200.27 | 293.66 | 1,116.52 | 266.78 | 190.53 | 220.02 | 168.85 |
| Inventory Days | 651.17 | 203.01 | 142.98 | 94.16 | 88.16 | 264.78 | 153.22 | 557.06 | 166.03 | 152.79 | 215.70 | 116.49 |
| Days Payable | 300.21 | 5.66 | 170.67 | 0.20 | 90.06 | 101.36 | 272.04 | 921.19 | 300.42 | 87.99 | 28.46 | 261.34 |
| Cash Conversion Cycle | 350.96 | 197.35 | 141.35 | 167.04 | 99.06 | 363.70 | 174.84 | 752.39 | 132.38 | 255.33 | 407.27 | 24.00 |
| Working Capital Days | 1,449.57 | 109.29 | 67.81 | 143.51 | 93.80 | 285.24 | 155.13 | 761.45 | 28.13 | 399.00 | 1,853.57 | 682.61 |
| ROCE % | 3.29% | 2.68% | 1.82% | 3.00% | 3.62% | 3.86% | 4.95% | 1.74% | 5.79% | 4.54% | 3.52% | 2.22% |
Documents
Announcements
-
Board Meeting Outcome for Submission Of Additional Attachment Required For Corporate Announcement Filed
Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - ( Ref: Previous Outcome Dated
147 November, 2025).
18 Nov - Unaudited Q2/H1 results for Sep 30, 2025; Manoj Chourasiya resigned Oct 13, 2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 Nov - Newspaper clipping of unaudited Financial Results for Quarter and Half year ended September 30th, 2025.
-
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of KCL Infra Projects Limited.
14 Nov - Approved unaudited results for quarter/half-year ended 30 Sep 2025; limited review; resignation of Manoj Kumar Chourasiya.
-
Outcome Of The Meeting Of The Board Of KCL Infra Projects Limited.
14 Nov - Unaudited results for quarter/half-year ended 30 Sep 2025; net loss Rs33.25 lakh; limited review; director resigned.
-
Board Meeting Intimation for Intimation Of Meeting Of The Board Under The Regulation 29 Of The SEBI (LODR), Regulations, 2015.
5 Nov - Board meeting on Nov 5 for unaudited Q2/H1 results (30 Sep 2025); Executive Director Manoj Chaurasiya resigned.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
KCLIPL is an infrastructure and construction company with a specialized focus on the
health sector. Additionally, it is also engaged
in providing advisory services.
The company is working on the ongoing
projects from FY23, i.e. BVG Satellite Channel. With this, it is going to apply for a non-news TV channel under the name Yuvan, and the company has also received a trademark for the same. KCL is also going to develop health care centres under the name C3 Multi-speciality Hospital Limited in various rural areas.